Personal Finance

Months after cancer drug trial, Merus agrees to be bought at 41% premium

By Samarth Pophale

September 29, 2025

13

Must read

Samarth Pophale http://finnoexpert.com/

Merus agreed to be bought for a 41% premium, months after a positive trial of a cancer drug.

Source link

Previous article

Watershed mapping project shows rapid loss of forests, offers new view of Va.’s changing landscapes

Next article

Heavy JSO presence in Murray Hill, active crime scene

- Advertisement -

More articles

LEAVE A REPLY Cancel reply

- Advertisement -

Latest article